Get Started

INKT

NASD MiNK Therapeutics, Inc.
Nov 5, 2026 · 12:56 PM ET DELAYED Market Open

$9.88 ↓ -0.73 (-6.84%) Trading Down from the previous close of $10.60, $0.72 below the day’s high of $10.59

YTD change
-11.43%
vs 20-day SMA
-5.36%
vs 200-day SMA
-12.42%

Price ranges

Previous day
$10.60 $11.03
open $11.03 close $10.60
-$0.43 (-3.90%)
Today
$9.61 $10.59
open $10.72 now $9.88
-$0.85 (-7.88%)
Past week
$10.35 $11.48
from $10.80 now $9.88
-$0.93 (-8.56%)
Past month
$9.19 $11.68
from $11.42 now $9.88
-$1.55 (-13.53%)
This year
$8.48 $16.93
from $11.15 now $9.88
-$1.28 (-11.43%)

Price & Performance

-0.94 (-8.14%) / 6M

$9.14$10.44$11.73$13.03May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 95.5% away from all-time highs of $221.55
  • INKT is down 11% since the beginning of the year
  • INKT is down 24% over the past 12 months
  • INKT is down 14% over the past 1 month
  • 2% of all INKT investors are betting against INKT

INKT reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -18.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.62
Earnings momentum +6.1% Quarterly EPS growth
Quarterly change +6.1%

Valuation

P/E ratio N/A
Enterprise value $44.4M
Beta 0.94

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$8.8M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $50.4M

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.